{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:37Z","timestamp":1787002837270,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205174\/Z\/16\/Z"],"award-info":[{"award-number":["205174\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Biomedical Research Centre at Moorfields and UCL Institute of Ophthalmology and PTC Therapeutics, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the retinal changes in choroideremia (CHM) patients to determine correlations between age, structure and function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects\/Methods<\/jats:title>\n                    <jats:p>\n                      Twenty-six eyes from 13 male CHM patients were included in this prospective longitudinal study. Participants were divided into &lt;50-year (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098) and \u226550-year (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095) old groups. Patients were seen at baseline, 6-month, and 1-year visits. Optical coherence tomography (OCT), OCT angiography, and fundus autofluorescence were performed to measure central foveal (CFT) and subfoveal choroidal thickness (SCT), as well as areas of preserved choriocapillaris (CC), ellipsoid zone (EZ), and autofluorescence (PAF). Patients also underwent functional investigations including visual acuity (VA), contrast sensitivity (CS), colour testing, microperimetry, dark adaptometry, and handheld electroretinogram (ERG). Vision-related quality-of-life was assessed by using the NEI-VFQ-25 questionnaire.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the 1-year follow-up period, progressive loss was detected in SCT, EZ, CC, PAF, and CFT. Those \u226550-years exhibited more structural and functional defects with SCT, EZ, CC, and PAF showing strong correlation with patient age (\n                      <jats:italic>rho<\/jats:italic>\n                      \u2009\u2264\u2009\u22120.47,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.02). CS and VA did not change over the year, but CS was significantly correlated with age (\n                      <jats:italic>rho<\/jats:italic>\n                      \u2009=\u2009\u22120.63,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Delayed to unmeasurable dark adaptation, decreased colour discrimination and no detectable ERG activity were observed in all patients. Minimal functional deterioration was observed over one year with a general trend of slower progression in the \u226550-years group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Quantitative structural parameters including SCT, CC, EZ, and PAF are most useful for disease monitoring in CHM. Extended follow-up studies are required to determine longitudinal functional changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-020-0974-1","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T06:03:09Z","timestamp":1590645789000},"page":"838-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prospective deep phenotyping of choroideremia patients using multimodal structure-function approaches"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-7885","authenticated-orcid":false,"given":"Ahmed M.","family":"Hagag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mitsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8582-4823","authenticated-orcid":false,"given":"Alessandro","family":"Abbouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Dubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-5360","authenticated-orcid":false,"given":"Mariya","family":"Moosajee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ejhg.2013.183","volume":"22","author":"M Moosajee","year":"2014","unstructured":"Moosajee M, Ramsden SC, Black GC, Seabra MC, Webster AR. Clinical utility gene card for: choroideremia. Eur J Hum Genet. 2014;22:572.","journal-title":"Eur J Hum Genet"},{"key":"974_CR2","doi-asserted-by":"crossref","first-page":"251584141881749","DOI":"10.1177\/2515841418817490","volume":"10","author":"A Mitsios","year":"2018","unstructured":"Mitsios A, Dubis AM, Moosajee M. Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments. Ther Adv Ophthalmol. 2018;10:2515841418817490.","journal-title":"Ther Adv Ophthalmol"},{"key":"974_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/13816810.2011.620056","volume":"33","author":"RG Coussa","year":"2012","unstructured":"Coussa RG, Traboulsi EI. Choroideremia: a review of general findings and pathogenesis. Ophthalmic Genet. 2012;33:57\u201365.","journal-title":"Ophthalmic Genet."},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.8380507","volume":"259","author":"MC Seabra","year":"1993","unstructured":"Seabra MC, Brown MS, Goldstein JL. Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. Science. 1993;259:377\u201381.","journal-title":"Science."},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","volume":"383","author":"RE MacLaren","year":"2014","unstructured":"MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet. 2014;383:1129\u201337.","journal-title":"Lancet."},{"key":"974_CR6","first-page":"6401","volume":"60","author":"RM Huckfeldt","year":"2019","unstructured":"Huckfeldt RM, Aleman TS, Doan T, Wen X-H, Weigel-DiFranco C, Chung DC, et al. Subfoveal gene augmentation therapy for choroideremia: one-year results from a Phase I\/II trial of AAV2-hCHM. Investigative Ophthalmol Vis Sci. 2019;60:6401.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1093\/hmg\/ddw184","volume":"25","author":"M Moosajee","year":"2016","unstructured":"Moosajee M, Tracey-White D, Smart M, Weetall M, Torriano S, Kalatzis V, et al. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model. Hum Mol Genet. 2016;25:3416\u201331.","journal-title":"Hum Mol Genet"},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3928\/23258160-20170829-05","volume":"48","author":"A Abbouda","year":"2017","unstructured":"Abbouda A, Lim WS, Sprogyte L, Webster AR, Moosajee M. Quantitative and qualitative features of spectral-domain optical coherence tomography provide prognostic indicators for visual acuity in patients with choroideremia. Ophthalmic Surg Lasers Imaging Retin. 2017;48:711\u20136.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/tjo.tjo_31_17","volume":"7","author":"AM Hagag","year":"2017","unstructured":"Hagag AM, Gao SS, Jia Y, Huang D. Optical coherence tomography angiography: technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol. 2017;7:115\u201329.","journal-title":"Taiwan J Ophthalmol"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/eye.2017.242","volume":"32","author":"A Abbouda","year":"2018","unstructured":"Abbouda A, Dubis AM, Webster AR, Moosajee M. Identifying characteristic features of the retinal and choroidal vasculature in choroideremia using optical coherence tomography angiography. Eye (Lond). 2018;32:563\u201371.","journal-title":"Eye (Lond)"},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1097\/IAE.0000000000002118","volume":"39","author":"M Battaglia Parodi","year":"2019","unstructured":"Battaglia Parodi M, Arrigo A, MacLaren RE, Aragona E, Toto L, Mastropasqua R, et al. Vascular alterations revealed with optical coherence tomography angiography in patients with choroideremia. Retina 2019;39:1200\u20135.","journal-title":"Retina"},{"key":"974_CR12","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1167\/iovs.15-18362","volume":"57","author":"JK Jolly","year":"2016","unstructured":"Jolly JK, Edwards TL, Moules J, Groppe M, Downes SM, MacLaren RE. A qualitative and quantitative assessment of fundus autofluorescence patterns in patients with choroideremia. Invest Ophthalmol Vis Sci. 2016;57:4498\u2013503.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/bjo.86.6.658","volume":"86","author":"MF Roberts","year":"2002","unstructured":"Roberts MF, Fishman GA, Roberts DK, Heckenlively JR, Weleber RG, Anderson RJ, et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia. Br J Ophthalmol. 2002;86:658\u201362.","journal-title":"Br J Ophthalmol"},{"key":"974_CR14","doi-asserted-by":"publisher","first-page":"2066 e1","DOI":"10.1016\/j.ophtha.2006.05.045","volume":"113","author":"AB Renner","year":"2006","unstructured":"Renner AB, Kellner U, Cropp E, Preising MN, MacDonald IM, van den Hurk JA, et al. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology. 2006;113:2066 e1\u201310.","journal-title":"Ophthalmology."},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0002-9394(98)00408-5","volume":"127","author":"H Hirakawa","year":"1999","unstructured":"Hirakawa H, Iijima H, Gohdo T, Imai M, Tsukahara S. Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia. Am J Ophthalmol. 1999;127:436\u201342.","journal-title":"Am J Ophthalmol"},{"key":"974_CR16","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1167\/iovs.17-22486","volume":"58","author":"JK Jolly","year":"2017","unstructured":"Jolly JK, Xue K, Edwards TL, Groppe M, MacLaren RE. Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging. Invest Ophthalmol Vis Sci. 2017;58:5575\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"974_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1167\/iovs.13-13745","volume":"55","author":"GR Jackson","year":"2014","unstructured":"Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:1427\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"974_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119:1050\u20138.","journal-title":"Arch Ophthalmol."},{"key":"974_CR19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/sim.1519","volume":"22","author":"J Shao","year":"2003","unstructured":"Shao J, Zhong B. Last observation carry-forward and last observation analysis. Stat Med. 2003;22:2429\u201341.","journal-title":"Stat Med"},{"key":"974_CR20","first-page":"665","volume":"22","author":"S Kim","year":"2015","unstructured":"Kim S. ppcor: an R package for a fast calculation to semi-partial correlation coefficients. Commun Stat Appl Methods 2015;22:665\u201374.","journal-title":"Commun Stat Appl Methods"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajo.2019.02.034","volume":"204","author":"AM Hagag","year":"2019","unstructured":"Hagag AM, Wang J, Lu K, Harman G, Weleber RG, Huang D, et al. Projection-resolved optical coherence tomographic angiography of retinal plexuses in retinitis pigmentosa. Am J Ophthalmol. 2019;204:70\u20139.","journal-title":"Am J Ophthalmol"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.oret.2017.07.022","volume":"2","author":"AM Hagag","year":"2018","unstructured":"Hagag AM, Pechauer AD, Liu L, Wang J, Zhang M, Jia Y, et al. OCT angiography changes in the 3 parafoveal retinal plexuses in response to hyperoxia. Ophthalmol Retin. 2018;2:329\u201336.","journal-title":"Ophthalmol Retin"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/bjophthalmol-2019-314243","volume":"104","author":"AM Hagag","year":"2020","unstructured":"Hagag AM, Mitsios A, Gill JS, Nunez Do Rio JM, Theofylaktopoulos V, Houston S, et al. Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in USH2A and MYO7A. Br J Ophthalmol. 2020;104:480\u20136.","journal-title":"Br J Ophthalmol"},{"key":"974_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2017.05.002","volume":"179","author":"AH Hariri","year":"2017","unstructured":"Hariri AH, Velaga SB, Girach A, Ip MS, Le PV, Lam BL, et al. Measurement and reproducibility of preserved ellipsoid zone area and preserved retinal pigment epithelium area in eyes with choroideremia. Am J Ophthalmol. 2017;179:110\u20137.","journal-title":"Am J Ophthalmol"},{"key":"974_CR25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/IAE.0000000000000765","volume":"35","author":"RF Spaide","year":"2015","unstructured":"Spaide RF, Fujimoto JG, Waheed NK. Image artifacts in optical coherence tomography angiography. Retina. 2015;35:2163\u201380.","journal-title":"Retina."},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00417-015-2976-4","volume":"253","author":"IP Seitz","year":"2015","unstructured":"Seitz IP, Zhour A, Kohl S, Llavona P, Peter T, Wilhelm B, et al. Multimodal assessment of choroideremia patients defines pre-treatment characteristics. Graefes Arch Clin Exp Ophthalmol. 2015;253:2143\u201350.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"974_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0161-6420(87)33479-7","volume":"94","author":"JD Cameron","year":"1987","unstructured":"Cameron JD, Fine BS, Shapiro I. Histopathologic observations in choroideremia with emphasis on vascular changes of the uveal tract. Ophthalmology. 1987;94:187\u201396.","journal-title":"Ophthalmology."},{"key":"974_CR28","first-page":"565","volume":"54","author":"CJ Mc","year":"1950","unstructured":"Mc CJ. The pathologic findings in two cases of choroideremia. Trans Am Acad Ophthalmol Otolaryngol. 1950;54:565\u201372.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/eye.2010.157","volume":"25","author":"MA Genead","year":"2011","unstructured":"Genead MA, Fishman GA. Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond). 2011;25:84\u201390.","journal-title":"Eye (Lond)"},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/IAE.0b013e3182215ae9","volume":"32","author":"MA Genead","year":"2012","unstructured":"Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina. 2012;32:826\u201333.","journal-title":"Retina."},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"OCT377","DOI":"10.1167\/iovs.15-18421","volume":"57","author":"E Heon","year":"2016","unstructured":"Heon E, Alabduljalil T, McGuigan ID, Cideciyan AV, Li S, Chen S, et al. Visual function and central retinal structure in choroideremia. Invest Ophthalmol Vis Sci. 2016;57:OCT377\u201387.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"974_CR32","doi-asserted-by":"crossref","unstructured":"Davson H. Electrophysiology of the retina: response to stimulation and the transduction process. In: Davson H, editor. Physiology of the Eye. 5 ed. London: Macmillan Press; 1990. p. 279\u2013304.","DOI":"10.1007\/978-1-349-09997-9_10"},{"key":"974_CR33","first-page":"35","volume":"50","author":"G Arden","year":"1979","unstructured":"Arden G. Measuring contrast sensitivity with gratings: A new simple technique for the early diagnosis of retinal and neurological disease. J Am Optom Assoc. 1979;50:35\u20139.","journal-title":"J Am Optom Assoc"},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00417-018-3921-0","volume":"256","author":"IP Seitz","year":"2018","unstructured":"Seitz IP, Jolly JK, Dominik Fischer M, Simunovic MP. Colour discrimination ellipses in choroideremia. Graefes Arch Clin Exp Ophthalmol. 2018;256:665\u201373.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"974_CR35","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ajo.2015.06.018","volume":"160","author":"JK Jolly","year":"2015","unstructured":"Jolly JK, Groppe M, Birks J, Downes SM, MacLaren RE. Functional defects in color vision in patients with choroideremia. Am J Ophthalmol. 2015;160:822\u201331 e3.","journal-title":"Am J Ophthalmol"},{"key":"974_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1076\/opge.24.4.203.17232","volume":"24","author":"G Rudolph","year":"2003","unstructured":"Rudolph G, Preising M, Kalpadakis P, Haritoglou C, Lang GE, Lorenz B. Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet. 2003;24:203\u201314.","journal-title":"Ophthalmic Genet"},{"key":"974_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1076\/opge.20.2.107.2285","volume":"20","author":"M Hayakawa","year":"1999","unstructured":"Hayakawa M, Fujiki K, Hotta Y, Ito R, Ohki J, Ono J, et al. Visual impairment and REP-1 gene mutations in Japanese choroideremia patients. Ophthalmic Genet. 1999;20:107\u201315.","journal-title":"Ophthalmic Genet."},{"key":"974_CR38","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1167\/iovs.16-19338","volume":"57","author":"IS Dimopoulos","year":"2016","unstructured":"Dimopoulos IS, Tseng C, MacDonald IM. Microperimetry as an outcome measure in choroideremia trials: reproducibility and beyond. Invest Ophthalmol Vis Sci. 2016;57:4151\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"974_CR39","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/hmg\/ddz028","volume":"28","author":"H Sarkar","year":"2019","unstructured":"Sarkar H, Mitsios A, Smart M, Skinner J, Welch AA, Kalatzis V, et al. Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics. Hum Mol Genet. 2019;28:1865\u201371.","journal-title":"Hum Mol Genet"},{"key":"974_CR40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41591-018-0185-5","volume":"24","author":"K Xue","year":"2018","unstructured":"Xue K, Jolly JK, Barnard AR, Rudenko A, Salvetti AP, Patricio MI, et al. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med. 2018;24:1507\u201312.","journal-title":"Nat Med."},{"key":"974_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamaophthalmol.2017.3904","volume":"135","author":"A Uji","year":"2017","unstructured":"Uji A, Balasubramanian S, Lei J, Baghdasaryan E, Al-Sheikh M, Sadda SR. Choriocapillaris imaging using multiple en face optical coherence tomography angiography image averaging. JAMA Ophthalmol. 2017;135:1197\u2013204.","journal-title":"JAMA Ophthalmol"},{"key":"974_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1364\/BOE.8.000048","volume":"8","author":"SS Gao","year":"2017","unstructured":"Gao SS, Patel RC, Jain N, Zhang M, Weleber RG, Huang D, et al. Choriocapillaris evaluation in choroideremia using optical coherence tomography angiography. Biomed Opt Express. 2017;8:48\u201356.","journal-title":"Biomed Opt Express"},{"key":"974_CR43","doi-asserted-by":"publisher","first-page":"e201700313","DOI":"10.1002\/jbio.201700120","volume":"11","author":"SS Gao","year":"2018","unstructured":"Wang Z, Camino A, Hagag AM, Wang J, Weleber RG, Yang P, et al. Automated detection of preserved photoreceptor on optical coherence tomography in choroideremia based on machine learning. J Biophotonics. 2018;11:e201700313.","journal-title":"J Biophotonics"},{"key":"974_CR44","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1364\/BOE.9.003092","volume":"9","author":"A Camino","year":"2018","unstructured":"Camino A, Wang Z, Wang J, Pennesi ME, Yang P, Huang D, et al. Deep learning for the segmentation of preserved photoreceptors on en face optical coherence tomography in two inherited retinal diseases. Biomed Opt Express. 2018;9:3092\u2013105.","journal-title":"Biomed Opt Express"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0974-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T05:29:03Z","timestamp":1632979743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0974-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-0974-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}